Chart calendar Oragenics Inc
Upcoming events on Oragenics Inc
Past events on Oragenics Inc
13/05/2024 | Q1 2024 Earnings Release (Projected) |
07/03/2024 | Investor Meeting |
14/12/2023 07:30 pm | Annual General Meeting |
03/04/2023 | World Vaccine Congress |
23/01/2023 | Reverse Split: 1 of 60 |
23/01/2023 | Reverse Split: 1 of 60 |
16/12/2022 07:30 pm | Annual General Meeting |
03/11/2022 11:35 pm | BioFlorida Conference |
10/08/2022 02:08 am | Interim 2022 Earnings Release |
14/05/2022 02:44 am | Q1 2022 Earnings Release |
26/02/2022 02:30 am | Annual General Meeting |
14/12/2021 11:30 pm | Alliance Global Partners Virtual Conference |
22/11/2021 07:30 pm | Annual General Meeting - Third Call |
24/08/2021 01:30 am | Annual General Meeting - Second Call |
30/06/2021 06:30 pm | Annual General Meeting |
15/03/2021 | Roth Virtual Conference |
09/03/2021 | H.C. Wainwright Global Life Science Conference |
16/09/2020 08:30 pm | H.C. Wainwright & Co., LLC Global Investment Conference |
21/08/2020 06:30 pm | Annual General Meeting |
10/06/2020 11:40 pm | Virtual Summer Investor Summit |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,09 0,00 - | 0,13 0,10 31.52% |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -15,9 -16,8 5.38% | -26,6 -26,3 -1.3% | -15,8 -18,5 14.61% | -14,4 -18,3 21.23% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,6 -16,5 5.73% | -26,4 -26,1 -1.27% | -15,7 -18,4 14.75% | -14,3 -18,2 21.49% |
Net income Million USD | Released Forecast Spread | -15,6 -16,5 5.73% | -26,4 -26,1 -1.27% | -15,7 -18,4 14.75% | -14,3 -18,2 21.49% |
EPS USD | Released Forecast Spread | -22,2 -23,4 5.13% | -28,2 -27,6 -2.17% | -8,40 -9,60 12.5% | -7,11 -9,60 25.94% |
Announcement Date | 04/03/20 | 01/03/21 | 24/03/22 | 17/04/23 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,09 0,00 - | 0,02 0,00 - | 0,03 0,00 - | 0,09 0,00 - | 0,00 0,00 - | 0,02 0,00 - |
EBIT Million USD | Released Forecast Spread | -2,30 -5,00 53.98% | -6,05 -2,70 -124.24% | -4,05 -5,10 20.64% | -3,95 -5,40 26.79% | -0,36 -4,20 91.42% | -2,90 -5,40 46.21% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,29 -5,01 54.24% | -6,04 -2,70 -123.53% | -4,03 -5,10 20.93% | -3,92 -5,40 27.45% | -0,30 -4,20 92.79% | -2,84 -5,40 47.32% |
Net income Million USD | Released Forecast Spread | -2,29 -5,01 54.24% | -6,04 -2,70 -123.53% | -4,03 -5,10 20.93% | -3,92 -5,40 27.45% | -0,30 -4,20 92.79% | -2,84 -5,40 47.32% |
EPS USD | Released Forecast Spread | -1,20 -2,40 50% | -3,00 -1,20 -150% | -1,80 -2,40 25% | -1,80 -3,00 40% | -0,54 -2,40 77.5% | -1,41 -3,00 53% |
Announcement Date | 24/03/22 | 13/05/22 | 09/08/22 | 14/11/22 | 17/04/23 | 12/05/23 |
16/05/2024 | BIOCON LIMITED: Q4 2024 Earnings Release |
16/05/2024 06:30 pm | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
24/07/2024 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
25/07/2024 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
25/07/2024 10:30 am | ARGENX SE: Q2 2024 Earnings Release |
30/07/2024 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
30/07/2024 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
30/07/2024 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
31/07/2024 | CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected) |